Venus Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2025 ,inter alia, to consider and approve This is to inform you that the ....
VENUSREM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Venus Remedies has informed the exchanges that its Board of Directors will meet on 26 May 2025 to consider and approve the audited standalone and consolidated financial results for the quarter and full year ended 31 March 2025. The company has also noted that the trading window for designated persons is already closed from 1 April 2025 and will remain so until 48 hours after the results are declared. The disclosure is filed under Regulation 29(1) of SEBI's Listing Obligations and Disclosure Requirements. No other specific business item has been mentioned besides any other matter with the Chair's permission.
This is a routine pre-results announcement, so there is no immediate price impact. The actual financial performance for FY25 will only be known once the results are approved and filed on 26 May 2025.